van Bergen P - Search Results

1

Anti-HBs after hepatitis B immunization with plasma-derived and recombinant DNA-derived vaccines: binding to mutant HBsAg.

Heijtink RA, van Bergen P, van Roosmalen MH, Sünnen CM, Paulij WP, Schalm SW, Osterhaus AD. Heijtink RA, et al. Among authors: van roosmalen mh, van bergen p. Vaccine. 2001 Jun 14;19(27):3671-80. doi: 10.1016/s0264-410x(01)00082-2. Vaccine. 2001. PMID: 11395201

2

Anti-HBs characteristics after hepatitis B immunisation with plasma-derived and recombinant DNA-derived vaccines.

Heijtink RA, van Bergen P, Paulij WP, de Man RA, Osterhaus AD. Heijtink RA, et al. Among authors: van bergen p. Vaccine. 2000 Feb 14;18(15):1531-8. doi: 10.1016/s0264-410x(99)00433-8. Vaccine. 2000. PMID: 10618551

3

Administration of a human monoclonal antibody (TUVIRUMAB) to chronic hepatitis B patients pre-treated with lamivudine: monitoring of serum TUVIRUMAB in immune complexes.

Heijtink RA, van Nunen AB, van Bergen P, Ostberg L, Osterhaus AD, de Man RA. Heijtink RA, et al. Among authors: van nunen ab, van bergen p. J Med Virol. 2001 Aug;64(4):427-34. doi: 10.1002/jmv.1068. J Med Virol. 2001. PMID: 11468726 Clinical Trial.

4

Characterization of a human monoclonal antibody obtained after immunization with plasma vaccine and a booster with recombinant-DNA hepatitis B vaccine.

Heijtink RA, Kruining J, van Bergen P, de Rave S, van Hattum J, Schutten M, Osterhaus AD. Heijtink RA, et al. Among authors: van hattum j, van bergen p. J Med Virol. 2002 Mar;66(3):304-11. doi: 10.1002/jmv.2146. J Med Virol. 2002. PMID: 11793381

5

In vivo activity of a mixture of two human monoclonal antibodies (anti-HBs) in a chronic hepatitis B virus carrier chimpanzee.

Heijtink R, Paulij W, van Bergen P, van Roosmalen M, Rohm D, Eichentopf B, Muchmore E, de Man R, Osterhaus A. Heijtink R, et al. Among authors: van bergen p, van roosmalen m. J Gen Virol. 1999 Jun;80 ( Pt 6):1529-1535. doi: 10.1099/0022-1317-80-6-1529. J Gen Virol. 1999. PMID: 10374972 Free article.

6

Seal gammaherpesviruses: identification, characterisation and epidemiology.

Martina BE, Verjans GM, Harder TC, Kuiken T, van de Bildt MW, van Bergen PA, Osterhaus AD. Martina BE, et al. Among authors: van de bildt mw, van bergen pa. Virus Res. 2003 Jul;94(1):25-31. doi: 10.1016/s0168-1702(03)00120-5. Virus Res. 2003. PMID: 12837554

7

Combined strategy of upfront CTCA and optimal treatment for stable chest pain: rationale and design of the CLEAR-CAD trial.

Verpalen VA, Coerkamp CF, Hinderks MJ, Meeder JG, Winter MM, Arkenbout EK, Vis JC, Habets J, Smulders MW, Mihl C, van Ofwegen-Hanekamp CEE, van der Spoel TIG, Tanis W, van Gelder RE, van der Wielen MLJ, Somsen GA, Kikkert WJ, Carati LF, El Barzouhi A, van Bergen PFMM, Dedic A, Prokop M, Stallmann HP, Beele XDY, Quarles van Ufford HME, Nijveldt R, Dijkgraaf MGW, Damman P, Planken RN, Henriques JPS; CLEAR-CAD investigators. Verpalen VA, et al. Among authors: van bergen pfmm. Neth Heart J. 2024 Nov;32(11):387-396. doi: 10.1007/s12471-024-01906-3. Epub 2024 Oct 18. Neth Heart J. 2024. PMID: 39422833 Free PMC article.

8

Which LGBTQ+ Inclusive School Strategies Support LGBTQ+ Student, Staff and Parent Perceptions of School Climate? A Latent Class Analysis.

Mann T, Burns E, Van Bergen P, Jones T. Mann T, et al. Among authors: van bergen p. J Homosex. 2024 Aug 5:1-27. doi: 10.1080/00918369.2024.2384933. Online ahead of print. J Homosex. 2024. PMID: 39101711 Free article.

9

Apolipoprotein A1 Infusions and Cardiovascular Outcomes after Acute Myocardial Infarction.

Gibson CM, Duffy D, Korjian S, Bahit MC, Chi G, Alexander JH, Lincoff AM, Heise M, Tricoci P, Deckelbaum LI, Mears SJ, Nicolau JC, Lopes RD, Merkely B, Lewis BS, Cornel JH, Trebacz J, Parkhomenko A, Libby P, Sacks FM, Povsic TJ, Bonaca M, Goodman SG, Bhatt DL, Tendera M, Steg PG, Ridker PM, Aylward P, Kastelein JJP, Bode C, Mahaffey KW, Nicholls SJ, Pocock SJ, Mehran R, Harrington RA; AEGIS-II Committees and Investigators. Gibson CM, et al. N Engl J Med. 2024 May 2;390(17):1560-1571. doi: 10.1056/NEJMoa2400969. Epub 2024 Apr 6. N Engl J Med. 2024. PMID: 38587254 Clinical Trial.

10

The impact of patient-reported frailty on cardiovascular outcomes in elderly patients after non-ST-acute coronary syndrome.

van den Broek WWA, Gimbel ME, Hermanides RS, Runnett C, Storey RF, Knaapen P, Emans ME, Oemrawsingh RM, Cooke J, Galasko G, Walhout R, Stoel MG, von Birgelen C, van Bergen PFMM, Brinckman SL, Aksoy I, Liem A, Van't Hof AWJ, Jukema JW, Heestermans AACM, Nicastia D, Alber H, Austin D, Nasser A, Deneer V, Ten Berg JM. van den Broek WWA, et al. Among authors: van bergen pfmm. Int J Cardiol. 2024 Jun 15;405:131940. doi: 10.1016/j.ijcard.2024.131940. Epub 2024 Mar 7. Int J Cardiol. 2024. PMID: 38458385 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

92 results

Search Page

Filters